AI-POWEREDPROSTATE CANCER DETECTION
Revolutionizing Prostate MRI Analysis with Advanced Deep Learning
Our cutting-edge AI solution transforms multiparametric MRI interpretation for prostate cancer detection. Leveraging deep learning trained on thousands of mpMRI scans, our system detects clinically significant prostate cancer with superior accuracy, reduces false positives by 50%, and minimizes unnecessary biopsies—enabling earlier diagnosis and better patient outcomes.
AI detects 7% more clinically significant prostate cancers than radiologists using PI-RADS
The landmark PI-CAI international study demonstrated that our AI system outperforms radiologists in detecting clinically significant prostate cancer on MRI while reducing false positives by 50%—a breakthrough that transforms prostate cancer screening and diagnosis.
ADVANCED FEATURES
Comprehensive AI capabilities for superior prostate MRI analysis
Deep Learning Analysis
Advanced neural networks trained on thousands of multiparametric MRI scans to identify prostate cancer with exceptional precision.
Superior Detection Rate
7% higher detection of clinically significant prostate cancer compared to radiologist interpretation alone.
Reduced False Positives
50% reduction in false alarms, minimizing unnecessary biopsies and patient anxiety.
mpMRI Compatible
Supports multiparametric MRI analysis including T2-weighted, diffusion-weighted, and dynamic contrast-enhanced imaging.
PI-RADS Compliant
Automated lesion classification according to PI-RADS v2.1 standards for consistent reporting.
Rapid Processing
Real-time MRI analysis providing results in minutes for faster clinical decision-making.
Lesion Segmentation
Automatic prostate and lesion segmentation with 3D volume representation for precise localization.
93% Accuracy
Clinically validated detection accuracy across diverse patient populations and imaging protocols.
How It Works
AI-assisted workflow for enhanced prostate cancer detection
mpMRI Acquisition
Multiparametric MRI scans are acquired using standard imaging protocols including T2, DWI, and DCE sequences.
AI Processing
Deep learning algorithms automatically segment the prostate gland and analyze tissue characteristics across all MRI sequences.
Lesion Detection
AI identifies suspicious lesions, assigns PI-RADS scores, and generates 3D visualizations for precise localization.
Clinical Review
Radiologists review AI findings alongside their own assessment for comprehensive diagnosis and treatment planning.
Proven Clinical Impact
Real-world results from extensive clinical validation studies
Compared to radiologist-only interpretation
Validated across diverse populations
Reducing unnecessary follow-up procedures
In low-risk patients through accurate MRI
Why Choose Scanvue.ai?
Transforming prostate cancer detection with AI-powered MRI analysis
Earlier Detection
Identify clinically significant prostate cancer at earlier stages when treatment options are most effective.
Fewer Unnecessary Biopsies
Reduce unnecessary biopsies by up to 90% through accurate MRI-based risk stratification.
Radiologist Support
Augment radiologist expertise with AI-assisted second reading, improving diagnostic confidence and consistency.
Improved Efficiency
Streamline workflow with automated prostate volume measurements and lesion characterization.
Accessible Expertise
Bring specialist-level prostate MRI interpretation to facilities with limited access to experienced radiologists.
Advanced AI Technology
Powered by state-of-the-art deep learning for multiparametric MRI
Multiparametric MRI Analysis
Our AI system analyzes all sequences of multiparametric MRI (mpMRI) including T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) imaging to comprehensively assess prostate tissue characteristics.
The deep learning model has been trained on thousands of mpMRI scans with expert radiologist annotations, learning to identify patterns associated with clinically significant prostate cancer (Gleason score ≥7).
Clinical Integration
Seamless integration with existing radiology workflows and PACS systems ensures minimal disruption while maximizing diagnostic capabilities. Our DICOM-compatible system works with all major MRI manufacturers.
The AI serves as an intelligent assistant, providing radiologists with automated measurements, lesion detection, and PI-RADS scoring to enhance diagnostic confidence and reduce interpretation time.
Clinical Evidence
Backed by extensive research and real-world validation
PI-CAI International Study
The landmark PI-CAI study coordinated by Radboud University Medical Center compared AI algorithms with 62 radiologists in detecting prostate cancer on MRI. The AI system demonstrated 7% higher detection of clinically significant prostate cancer while reducing false positives by 50% compared to radiologists using PI-RADS v2.1.
Superior to Radiologist-Only Interpretation
Multiple studies have shown that AI-assisted MRI interpretation outperforms radiologists working alone. Research demonstrates that radiologist-AI collaboration achieves superior sensitivity and specificity compared to either radiologists or AI alone, representing the optimal approach for prostate cancer detection.
Extracapsular Extension Detection
Advanced AI tools have demonstrated exceptional performance in detecting extracapsular extension (cancer spreading beyond the prostate capsule), achieving an AUC of 0.88 for patient-level detection and 0.92 for MRI quality assessment, critical factors in treatment planning and surgical decision-making.
Deployment Scenarios
Versatile AI solution for diverse healthcare settings
Imaging Centers
Enhance prostate MRI interpretation in high-volume imaging centers with AI-assisted reading, improving detection rates and reducing radiologist workload.
Community Hospitals
Bring specialist-level prostate MRI expertise to facilities with limited access to experienced uroradiologists, improving diagnostic accuracy.
Urology Practices
Support urologists with AI-powered MRI analysis for better patient risk stratification, biopsy targeting, and treatment planning decisions.
Transform Your Prostate Cancer Detection Program
Join leading healthcare institutions worldwide using AI to detect prostate cancer earlier, reduce unnecessary biopsies, and improve patient outcomes through advanced multiparametric MRI analysis.